FT Health Interviews Founder, Managing Director Of Medicines Development For Global Health

FT Health: Sackler saga; health inequality: Ebola strikes again
The latest issue of the Financial Times’ weekly global health newsletter features an interview with Mark Sullivan, founder and managing director of Medicines Development for Global Health, who discusses the organization’s efforts to address scabies, including research on the anti-helminth drug Moxidectin. The newsletter also provides a roundup of global health-related news stories (Jack, 3/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.